A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses
- PMID: 2994784
A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses
Abstract
A comprehensive study was initiated to examine the immunologic status of a sample (n = 47) of the asymptomatic hemophilia A and B populations of metropolitan Atlanta and to determine if any of the abnormalities changed with time or correlated with infection by human T cell leukemia virus type III and lymphadenopathy-associated virus (HTLV-III/LAV) or other viruses either alone or in combination. Patients with hemophilia A (Hem-A) showed a defect in cellular immunity evidenced by a depressed T cell helper/suppressor ratio (P less than .0001), an increased absolute T suppressor cell number (P less than .0001), and a diminished number of T helper cells (P = .003) when compared with health professionals. Lymphocytes from these patients also showed a reduced ability to transform in response to phytohemagglutinin and pokeweed mitogen. No deterioration in immune status was seen during a median ten-month period of follow-up. Sixty-four percent of Hem-A patients had antibodies to HTLV-III/LAV and those who were seropositive had a significantly decreased helper/suppressor cell ratio (P = .018) and a diminished T helper cell number (P = .002); they were also more likely to have had exposure to cytomegalovirus than HTLV-III/LAV-negative Hem-A patients (P = .016). Heavy use of factor VIII concentrate was associated with a decreased number of T helper cells (P = .037) and seropositivity for HTLV-III/LAV (P = .011 in 1982). Hemophilia patients had higher IgG, immune complex, and beta 2-microglobulin levels than health professionals (P less than .0001). Although the most prominent abnormality observed in T cell subsets of patients with hemophilia is an increase in T suppressor cells, a finding likely to be associated with immune augmentation in response to multiple stimuli, the T cell abnormality that was predictive of exposure to HTLV-III/LAV, the putative acquired immunodeficiency syndrome agent, was a diminished number of T helper cells.
Similar articles
-
Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses.J Pediatr. 1986 Apr;108(4):504-10. doi: 10.1016/s0022-3476(86)80823-x. J Pediatr. 1986. PMID: 3007715
-
HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.AIDS Res. 1986 Feb;2(1):51-61. doi: 10.1089/aid.1.1986.2.51. AIDS Res. 1986. PMID: 2424467
-
HTLV III antibodies and immunological alterations in hemophilia patients.Klin Wochenschr. 1986 Feb 3;64(3):115-24. doi: 10.1007/BF01732634. Klin Wochenschr. 1986. PMID: 3005759
-
Immunopathogenesis of the acquired immunodeficiency syndrome.Ann Intern Med. 1985 Nov;103(5):704-9. doi: 10.7326/0003-4819-103-5-704. Ann Intern Med. 1985. PMID: 2996403 Review.
-
Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia.J Clin Immunol. 1986 Mar;6(2):121-9. doi: 10.1007/BF00918744. J Clin Immunol. 1986. PMID: 3086364 Review.
Cited by
-
Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up.Infection. 1987 Jul-Aug;15(4):248-52. doi: 10.1007/BF01644125. Infection. 1987. PMID: 3499399
-
Serological markers of hepatitis B virus and cytomegalovirus infections in Norwegians with coagulation factor defects.Blut. 1990 Feb;60(2):93-6. doi: 10.1007/BF01720514. Blut. 1990. PMID: 2154272
-
Effects of factor VIII concentrates on the immune system in hemophilic patients.Ann Hematol. 1991 Sep;63(3):145-51. doi: 10.1007/BF01703246. Ann Hematol. 1991. PMID: 1932290 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials